VRTX

VRTX Net Income Growth

21.10%TTM

Period ending:

VRTX TTM Net Income YoY %%
VRTX TTM Net Income YoY %1095.88%-1279.92%
1991-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

VRTX net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 139 observations from Dec 31, 1991 to Jun 30, 2026.

Vertex Pharmaceuticals Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
21.1018%
538.6996%
838.0881%
865.965%
842.5189%
-124.6032%
-114.7972%
-113.8283%
-114.5591%
23.3058%
8.9585%
6.0033%
5.3299%
32.9919%
41.8391%
50.4104%
60.3982%
-11.2591%
-13.6285%
-19.1219%
-4.2815%
82.8032%
130.4235%
25.4926%
-6.0739%
-29.8957%
-43.8785%
231.3644%
433.3585%
853.6946%
695.8343%
230.5591%
61.7073%
29.6303%
329.013%
187.5781%
192.7891%
143.4599%
79.3856%
66.0969%
62.2952%
43.0768%
24.4315%
-27.365%
-55.6503%
-90.7379%
-65.9596%
8.4605%
5.4509%
27.0757%
-315.7831%
-542.6428%
-222.7545%
-270.436%
-461.9125%
141.2817%
154.9547%
138.8346%
103.919%
57.7765%
-9.8039%
-18.7156%
-17.5104%
-17.0982%
-11.0731%
-22.4952%
-39.6491%
-55.1978%
-59.4558%
-29.4228%
-17.5251%
-21.1487%
-36.9607%
-71.2211%
-89.1233%
-52.9194%
-13.1133%
-13.7693%
-1.7078%
-4.6252%
-46.7605%
-22.4331%
-22.3583%
-26.4718%
21.1678%
20.1961%
-8.9173%
-14.4874%
-133.8565%
-224.045%
-40.5216%
-80.0672%
2.7892%
21.8796%
-52.5255%
-0.7436%
-63.4711%
-160.7804%
-79.5728%
-196.6185%

Compare net income growth

Other companies in Healthcare. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.